Merck KGaA Woos Investors Irked by ‘Bunker’ Culture, Dearth of New Drugs

Bloomberg -- Merck KGaA Chief Financial Officer- designate Matthias Zachert may make his first task repairing the German company’s relationship with investors and analysts as he seeks to revive one of Europe’s worst-performing drug stocks.

MORE ON THIS TOPIC